Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

Federal funding opportunity PAR-27-011 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes November 2, 2028

Program funding history

Synopsis

Who can apply

• City or township governments
• Private institutions of higher education
• Public housing authorities/Indian housing authorities
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Small businesses
• State governments
• Native American tribal governments (Federally recognized)
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Public and State controlled institutions of higher education
• Special district governments
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Independent school districts
• Native American tribal organizations (other than Federally recognized tribal governments)
• County governments
• For profit organizations other than small businesses

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

How to apply

Similar grants

• Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
  PAR-25-274 · National Institutes of Health · closes November 17, 2026
• Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
  PAR-25-268 · National Institutes of Health · closes November 17, 2026
• Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
  PAR-25-155 · National Institutes of Health · closes October 19, 2026
• Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
  PAR-25-144 · National Institutes of Health · closes January 7, 2028
• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
  PAR-25-143 · National Institutes of Health · closes January 7, 2028
• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
  PAR-25-233 · National Institutes of Health · closes January 7, 2028